Roche Molecular Systems Talent Acquisition Specialist Salaries in San Francisco
The average Roche Molecular Systems Talent Acquisition Specialist in San Francisco earns an estimated $125,394 annually, which includes an estimated base salary of $108,027 with a $17,367 bonus. Roche Molecular Systems' Talent Acquisition Specialist compensation is $29,934 more than the US average for a Talent Acquisition Specialist. Talent Acquisition Specialist salaries at Roche Molecular Systems in San Francisco can range from $63,000 - $205,000.
In San Francisco, The HR Department at Roche Molecular Systems earns $2,814 more on average than the Business Development Department.
Last updated a year ago.
- $108,027
- avg. base
- $17,367
- avg. bonus
Talent Acquisition Specialist Salaries at Roche Molecular Systems
In San Francisco, Talent Acquisition Specialists earn $861 more than Recruiters, and $17,525 less than HR Managers.
Compensation at Roche Molecular Systems by Department
In San Francisco, The HR Department averages $2,814 more than the Business Development Department, and $8,489 less than the Legal Department
Talent Acquisition Specialist Compensation by Gender (All Companies)
The average female Talent Acquisition Specialist at companies similar size to Roche Molecular Systems reported making $103,781, while the average male Talent Acquisition Specialist at similar sized companies reported making $118,755.
Talent Acquisition Specialist Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Talent Acquisition Specialist at companies similar size to Roche Molecular Systems reported making $122,536, while the average Hispanic or Latino Talent Acquisition Specialist at similar sized companies reported making $90,515.
How Talent Acquisition Specialists at Roche Molecular Systems Rate Their Compensation
The majority of Talent Acquisition Specialists at Roche Molecular Systems believe they're compensated fairly. 100% of Talent Acquisition Specialists at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
